Brief: China Biotech Services Sees Qtrly Net Loss Of Not Less Than HK$24 Mln
04/05/2020 13:28
May 4 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* FOR THREE MONTHS, EXPECTED TO RECORD A NET LOSS OF NOT
LESS THAN
HK$24 MILLION
* EXPECTED INCREASE Q1 NET LOSS DUE TO DROP IN REVENUE FROM
MEDICAL LABORATORY TESTING & HEALTH CHECK SERVICES SEGMENT
Source text for Eikon: urn:newsml:reuters.com:*:nHKS1dch22
Further company coverage: 8037.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)